- -

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis

Show full item record

Senabre-Gallego, JM.; Santos-Ramírez, C.; Santos-Soler, G.; Salas-Heredia, E.; Sánchez Barrioluengo, M.; Barber, X.; Rosas, J. (2013). Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. Patient Preference and Adherence. 7:961-972. doi:10.2147/PPA.S33109

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/84332

Files in this item

Item Metadata

Title: Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
Author:
UPV Unit: Universitat Politècnica de València. Instituto de Gestión de la Innovación y del Conocimiento - Institut de Gestió de la Innovació i del Coneixement
Universitat Politècnica de València. Departamento de Estadística e Investigación Operativa Aplicadas y Calidad - Departament d'Estadística i Investigació Operativa Aplicades i Qualitat
Issued date:
Abstract:
[EN] To date, anti-tumor necrosis factor alfa (anti-TNF-α) therapy is the only alternative to nonsteroidal anti-inflammatory drugs for the treatment of ankylosing spondylitis. Etanercept is a soluble TNF receptor, with ...[+]
Subjects: Ankylosing spondylitis , Etanercept, , Spondyloarthritis , Efficacy , Safety
Copyrigths: Reconocimiento - No comercial (by-nc)
Source:
Patient Preference and Adherence. (issn: 1177-889X )
DOI: 10.2147/PPA.S33109
Publisher:
Dove Medical Press
Publisher version: http://doi.org/10.2147/PPA.S33109
Type: Artículo

This item appears in the following Collection(s)

Show full item record